Education Information: Dr Vikram Sarabhai Centenary Celebrations Begin | Policy Indications: NITI Aayog Launches India Innovation Index 2019 | Policy Indications: Govt Get Going on Reducing Single Use Plastic | National Edu News: WBJEE 2020 Registrations - Begin Today Exam on February 2 | Leadership Instincts: Blockchain Investing Are Mostly Speculative As of Now | Technology Inceptions: Facebook unveils TV streaming devices | Science Innovations: Airborne bacteria from ocean seeding clouds | Teacher Insights: Beware of stress in parenting | Parent Interventions: Classroom Management Impacts Students | International Edu News: Oxford grabs top slot in varsity rankings | Cover Story: Mark of a School | Education Information: Delhi Asks Government Schools to Ensure Bag Weight Criteria | Management lessons: Employees Concerned About Job Meaning As Much as Pay Cheque | National Edu News: CBSE makes Mandatory for Schools to Become Water Efficient in Next Three Years. | Health Monitor: Protein Treatment to Supplement Insulin Therapy for Diabetes Developed |

June 17, 2019 Monday 01:52:50 PM IST

Killing drug-resistant bacteria

Scientists have used an experimental therapy that relies on bacteria-infecting viruses collected, in part, through Howard Hughes Medical Institute's programme to fight a Mycobacterium infection in a 15-year-old girl who had undergone a double lung transplant. Mycobacterium is a highly drug-resistant strain of bacteria. Weeks after the transplant, doctors noticed signs of infection in her liver. Then, they saw nodules - pockets of bacteria pushing up through the skin - on her arms, legs, and buttocks. The girl's infection had spread, and traditional antibiotics were no longer working.

A new personalised treatment has helped the girl heal. The treatment relies on genetically engineering bacteriophages, viruses that can infect and kill bacteria.
Researchers tweaked the phages' genomes to turn them into bacteria killers then made a cocktail of phages. Now doctors have successfully used phages to treat a patient with a multidrug-resistant bacterium.The idea is to use bacteriophages as antibiotics - as something we could use to kill bacteria that cause infection.